Trial Library, an oncology clinical trials company, today announced it has come out of stealth mode and received its first funding to address the need for equity in patient recruitment to oncology clinical trials. The $5 million seed round was led by Deena Shakir, Partner at Lux Capital, with participation from Julian Eison, Managing Partner at NEXT VENTŪRES, Unseen Capital, as well as other notable angel investors. This investment supports the growing need for more inclusivity in oncology clinical trials, and will expand the usage of the Trial Library platform among community oncologists who are patients' trusted sources for advice on clinical trials.

Trial Library is an oncology clinical trials company helping patients, providers, and pharmaceutical sponsors of clinical trials. With an unprecedented level of investment in cancer research that is poised to produce a vast new array of therapeutic options, Trial Library seeks to improve access for all patients right when therapies are available.